期刊文献+

动态监测PCT、CRP、NE在恶性肿瘤化疗后粒缺期患者中的临床价值 被引量:4

Clinical application value of dynamic monitoring of PCT,CRP and NE in patients with agranulocytosis after malignant tumor chemotherapy
下载PDF
导出
摘要 目的分析动态监测降钙素原(PCT)、C反应蛋白(CRP)和中性粒细胞(NE)对恶性肿瘤化疗后粒缺期患者的临床价值。方法选取该院2018年1月至2020年6月收治的恶性肿瘤化疗后粒缺期患者(n=411),根据合并发热的情况,分为发热感染组(n=167)和未发热组(n=244),比较各组PCT、CRP、NE差异,分析发热感染患者的病原菌分布。结果化疗前,各组PCT、CRP、NE差异无统计学意义(P>0.05);化疗后,发热感染组PCT、CRP、NE均高于未发热组,差异有统计学意义(P<0.05)。发热感染组大肠杆菌、真菌、金黄色葡萄球菌/溶血葡萄球菌、肺炎克雷伯杆菌是主要的病原种类,构成比分别为24.55%、20.36%、17.37%、12.57%,其中大肠杆菌、真菌、金黄色葡萄球菌/溶血葡萄球菌的构成比均在15%以上,明显高于其他病原种类构成比(P<0.05)。PCT、CRP、NE预测患者感染时的曲线下面积分别为0.952、0.860、0.897。结论动态监测PCT、CRP、NE可作为预测恶性肿瘤化疗后粒缺期患者病原菌感染种类及预后的重要指标。 Objective To analyze the diagnostic value of dynamic monitoring of procalcitonin(PCT),C-reactive protein(CRP)and neutrophils(NE)in the diagnosis of agranulocytosis after chemotherapy for malignant tumors.Methods Patients with agranulocytosis of malignant tumor after chemotherapy in hospital from January 2018 to June 2020(n=411)were selected and divided into the fever infection group(n=167)and the non-fever group(n=244)according whether there was fever.The differences of PCT,CRP and NE in each group were compared,and the distribution and composition of pathogenic bacteria in the fever infection group were analyzed.Results Before chemotherapy,there was no significant difference in PCT,CRP and NE between the two groups(P>0.05);while after chemotherapy,PCT,CRP and NE in the fever infection group were higher than those in the non-fever group,the difference was statistically significant(P<0.05).In the fever infection group,Escherichia coli,fungi,Staphylococcus aureus/haemolyticus,and Klebsiella pneumoniae were the main pathogens,and the proportions from high to low was 24.55%,20.36%,17.37%and 12.57%,respectively.The constituent ratios of Escherichia coli,fungi and Staphylococcus aureus/haemolyticus were all above 15%,which was significantly higher than that of other pathogens,the difference was statistically significant(P<0.05).The areas under the curve of PCT,CRP and NE in predicting infection was 0.952,0.860 and 0.897,respectively.Conclusion Dynamic monitoring of PCT,CRP and NE can be used as important indicators to predict the types of pathogenic bacteria and prognosis in patients with agranulocytosis after chemotherapy for malignant tumors.
作者 姜蓓 宋宁 张葆康 JIANG Bei;SONG Ning;ZHANG Baokang(Department of Laboratory Medicine,Qingdao Central Hospital Affiliated to Qingdao University,Qingdao,Shandong 266000,China)
出处 《重庆医学》 CAS 2022年第10期1696-1698,1702,共4页 Chongqing medicine
基金 山东省重大科技创新工程专项课题项目(2018SDKJ0404-3)。
关键词 恶性肿瘤 粒缺期 降钙素原 C反应蛋白 中性粒细胞 诊断价值 malignant tumors agranulocytosis procalcitonin C-reactive protein neutrophils diagnostic value
  • 相关文献

参考文献9

二级参考文献72

  • 1叶璐,李彩霞,吴德沛,孙爱宁.血液病化疗后致败血症68例临床分析[J].南通大学学报(医学版),2009,29(6):430-431. 被引量:4
  • 2Viallon A, Pouzet V, Z6ni F, Tardy B, Guyomarch S, Lambert C,Page Y, Bertrand JC. [ Rapid diagnosis of the type of meningitis (bacterial or viral) by the assay of serum procalcitonin ]. Presse Med. 2000 Mar 25;29(11) :584 -8.
  • 3French. Lin SG, Hou TY, Huang DH, He SY, Lin YD, Zhang LY, Hsieh PS. Role of procalcitonin in the diagnosis of severe infection in ped- iatric patients with fever and Neulropenia - a systemic review and meta - analysis. Pediatr Infect Dis J. 2012 Oct;31 (10) :e182 ~ 8.
  • 4Phillips RS, Wade R, Lehm~eher T, Stewart LA, Sutton AJ. Sys- tematic review and meta~ analysis of the value of initial biomarkers in predicting adverse outcome in febrile neutrepenic episodes in children and young people with cancer. BMC Med. 2012 Jan 18; 10:6.
  • 5Casey LC. Role of cytokines in the pathogerlesis of cardiopulmonary -induced multisystem organ failure. Ann Thorac Surg. 1993 Nov; 56(5 Suppl) :$92 ~6.
  • 6Panacek EA, Marshall JC, Albertson TE, Johnson DH, Johnson S, MacArthur RD, Miller M, Barchuk WT, Fischkoff S, Kaul M, Teoh L, Van Meter L, Daum L, Lemeshow S, Hicklin G, Doig C ; Monoclonal Anti -TNF: a Randomized Controlled Sepsis Study In- vestigators. Efficacy and safety of the monoclonal anti - tumor nec- rosis factor antibody F(ab') 2 fragment afelimomab in patients with severe sepsis and elevated interleukin - 6 levels. Grit Care Med. 2004 Nov-32(ll ) :2173 ~82.
  • 7Demirkaya M,Tugcu D,Akcay A,et al.Adrenomedullin-a new marker in febrile neutropenia:comparison with CRP and procalcitonin[J].Pediatr Hematol Oncol,2015,32(7):482-489.
  • 8Stuart RK,Cripe LD,Maris MB,et al.REVEAL-1,aphase 2dose regimen optimization study of vosaroxin in older poorrisk patients with previously untreated acute myeloid leukaemia[J].Br J Haematol,2015,168(6):796-805.
  • 9Koren-Michowitz M,Maayan H,Apel A,et al.Salvage therapy with ARA-C and gemtuzumab ozogamicin in AML patients relapsing after stem cell transplantation[J].Ann Hematol,2015,94(3):375-378.
  • 10Huang Z,Liu WJ,Guo QL,et al.Platelet parameters and expression of platelet membrane glycoprotein in childhood acute lymphoblastic leukemia[J].Genet Mol Res,2015,14(4):16074-16089.

共引文献65

同被引文献73

引证文献4

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部